Elcubragistat (INN; developmental code names ABX-1431, Lu-AG06466) is a monoacylglycerol lipase (MAGL) inhibitor which is or was under development for a variety of indications but has not completed development or been marketed as of 2025.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.